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Abstract: 
In this paper, we present a tissue metabonomic method with an optimized extraction procedure 
followed by instrumental analysis with gas chromatography/time-of-flight mass spectrometry 
(GC/TOFMS) and spectral data analysis with multivariate statistics. Metabolite extractions were 
carried out using three solvents: chloroform, methanol, and water, with design of experiment 
(DOE) theory and multivariate statistical analysis. A two-step metabolite extraction procedure 
was optimized using a mixed solvent of chloroform–methanol–water (1:2:1, v/v/v) and then 
followed by methanol alone. This approach was subsequently validated using standard 
compounds and liver tissues. Calibration curves were obtained in the range of 0.50–125.0 μg/mL 
for standards and 0.02–0.25 g/mL acceptable for liver tissue samples. For most of the 
metabolites investigated, relative standard deviations (RSD) were below 10% within a day 
(reproducibility) and below 15% within a week (stability). Rat liver tissues of carbon 
tetrachloride-induced acute liver injury models (n = 10) and healthy control rats (n = 10) were 
analyzed which demonstrated the applicability of the developed procedure for the tissue 
metabonomic study. 
 
Article: 
INTRODUCTION 
As end products of biochemical regulations and metabolism, metabolites represent the response 
to the genomic and environmental action of cells. The measurement of metabolome variations in 
response to stimuli has been widely used in modern pharmaceutical and biomedical research 
[1,2]. The main analytical methods employed for metabonomic studies are based on information-
rich spectroscopic techniques, such as nuclear magnetic resonance (NMR) spectrometry and 
mass spectrometry (MS), which is usually coupled with gas chromatography (GC/MS), liquid 
chromatography (LC/MS) or capillary electrophoresis (CE/MS) [3-5]. Metabonomic studies 
generate complex multivariate data that requires chemometrics for interpretation [6]. With 
unsupervised methods like principle components analysis (PCA) [7], and supervised methods 
such as partial least square (PLS) [8] and orthogonal partial least square (OPLS) analysis [9], 
researchers can obtain classification patterns and identify the compounds responsible for such 
patterns and grouping. 
 
Biofluids such as urine and blood are most frequently used in metabonomic studies, because they 
contain a wide variety of metabolites and can be obtained non-invasively. However, urine and 
blood metabonomics reflect the comprehensive metabolic effects associated with a pathogen or 
chemical agent stimuli; they are unable to provide the precise perspective of local metabolism 
and microenvironment [10]. Therefore, tissue-targeted technology has considerable value since 
many diseases may cause detectable disturbances only to the local metabolic pathways within 
specific organs [11]. Tissue-targeted metabonomic analyses have been carried out on brain tissue 
[11-13], liver tissue [14-16], and kidney tissue [17-19]. Metabolite extraction is a critical step in 
tissue metabonomic study, and the chloroform–methanol–water solvent system is considered the 
preferred method in several reports [20-23]. The latest relevant study was conducted by Wu et al. 
[24], in which fish liver was used to optimize the extraction strategy of the preferred solvent 
system for NMR- and FT-ICR MS-based metabonomic studies. However, the optimized ratio of 
solvent mixture and extraction method used specifically for GC/MS-based tissue metabonomics 
has not yet been determined. 
 
In this study, we combined design of experiment (DOE) theory [25] with multivariate statistical 
analysis to optimize the ratio of solvents in the preferred extraction system chloroform–
methanol–water and the method for maximum extraction of metabolites from rat liver tissue, 
using gas chromatography/time-of-flight mass spectrometry (GC/TOFMS). The methodology 
was then validated by method validations using standard compounds and liver tissues from 
healthy rats. The established procedure was then utilized to discriminate carbon tetrachloride 
(CCl4)-induced acute liver injury rats from healthy controls and to detect the metabolite 
variations in the liver tissues. 
 
MATERIALS AND METHODS 
Chemicals and reagents 
Ultrapure water from the Milli-Q system (Millipore, USA) was used in the experiments. 
Chromatographic grade methanol was purchased from Merck Chemicals (Germany). 
Chloroform, aether, olive oil, CCl4, pyridine, and anhydrous sodium sulfate were analytical 
grade and purchased from China National Pharmaceutical Group Corporation (Shanghai, China). 
l-2-chlorophenylalanine (Intechem Tech. Co., Ltd., Shanghai, China) and heptadecanoic acid 
(Sigma–Aldrich, St. Louis, MO, USA) served as internal standards. BSTFA (1% TMCS), 
methoxyamine, and the 29 standard compounds (Table 2) were purchased from Sigma–Aldrich 
(St. Louis, MO, USA) and properly stored before use. Superoxide dismutase (SOD) testing kits 
and malondialdehyde (MDA) testing kits were purchased from the Jiancheng Institute of 
Biotechnology (Nanjing, China). 
 
Animal handling and sampling 
Twenty male Sprague–Dawley rats weighing 220 ± 20 g were purchased from Shanghai 
Laboratory Animal Co., Ltd. (SLAC, Shanghai, China). The rats were maintained in a 12-h 
light/12-h dark cycle at 25 °C and 50% humidity, with free access to food and water. After a 
week acclimation, the rats were randomly divided into two groups: liver injury model group 
(n = 10) and control group (n = 10). The model rats received intra-peritoneal injections twice 
(24 h interval) with a dose of 1.5 mL/kg (body weight) CCl4 solution (diluted twofold with olive 
oil) to induce acute liver injury. The control rats received an equal volume of olive oil by intra-
peritoneal injections. All rats were sacrificed 24 h after the second injection, after collecting 
blood from the heart under aether anesthesia. The collected blood was clotted at room 
temperature and the serum was separated by centrifugation. Rat livers were removed from the 
body immediately after sacrifice and washed in ice-cold physical saline solution. The isolated 
livers and serum were stored at −80 °C until use. Liver tissues used in the following extraction 
investigations were chosen randomly from rats in the healthy control group. 
 
Extraction method 
One-step extraction. We investigated the ability of various ratios of the three solvents in the 
preferred solvent system – chloroform, methanol, and water – to extract metabolites from liver 
tissue. A total of 1000 μL solvent was used for each 100 mg of liver tissue. The volumes of 
chloroform and water were both limited to 250 μL of the total 1000-μL mixture (discussed 
below) and ten different solvent mixtures were obtained from a D-optional experimental design 
using MODDE software (Umetrics, Umeå, Sweden) (Table 1). Each experiment was performed 
twice to test its repeatability. The following process was used for metabolite extraction: liver 
tissues were weighed and homogenized with a T10 basic homogenizer (IKA, Staufen, Germany) 
for 30 s at 0 °C, then centrifuged at 12,000 rpm for 10 min at 4 °C. The resulting supernatant 
(300 μL) was transferred to a GC sampling vial containing two internal standards, l-2-
chlorophenylalanine (10 μL, 0.3 mg/mL) and heptadecanoic acid (10 μL, 1.0 mg/mL), then dried 
in a vacuum centrifuge concentrator before the subsequent derivatization. 
 
Table 1: Solvent mixtures tested in one-step extraction. 
No.a Chloroform Methanol Water v/v/vb 
01 0 μL 1000 μL 0 μL 0:1:0 
02 0 μL 750 μL 250 μL 0:3:1 
03 250 μL 500 μL 250 μL 1:2:1 
04 250 μL 750 μL 0 μL 1:3:0 
05 125 μL 875 μL 0 μL 1:7:0 
06 0 μL 875 μL 125 μL 0:7:1 
07 125 μL 750 μL 125 μL 1:6:1 
08 125 μL 625 μL 250 μL 1:5:2 
09 200 μL 600 μL 200 μL 1:3:1 
10 220 μL 560 μL 220 μL 2:5:2 
aEach experiment has one replicate. 
bChloroform:methanol:water, v/v/v. 
 
Two-step extraction. Based on the results of one-step extraction, a two-step extraction 
procedure was carried out. For each 100-mg liver tissue sample, 500 μL of each of the two 
solvents (the mixture of chloroform, methanol and water (1:2:1, v/v/v); and methanol alone) 
were used to determine the optimal order of the two extraction solvents. After homogenization 
with the first solvent and centrifugation, a 150-μL aliquot of supernatant was transferred to a GC 
sampling vial containing the internal standards and the deposit was re-homogenized with the 
second solvent before a second centrifugation. Another 150-μL aliquot of supernatant was added 
to the same vial for drying and then derivatization as described below. 
 
Method validation 
Linearity. The linearity of standards was determined by mixing 29 standard compounds (see 
Table 2) belonging to different chemical classes – amino acids, organic acids, carbohydrates, 
fatty acids, nucleotides – and diluted to concentrations of 0.004, 0.020, 0.050, 0.100, 0.200, 
0.400 and 1.000 of their original concentrations, ranging from 0.5 to 125 μg/mL or 1.0 to 
250 μg/mL. Each 100 μL mixture solution was added to the sampling vial with two internal 
standards, l-2-chlorophenylalanine (10 μL, 0.3 mg/mL) and heptadecanoic acid (10 μL, 
1.0 mg/mL), and then dried in a vacuum centrifuge concentrator before subsequent 
derivatization. 
 
Table 2: Linearity and detection limit of mixed standards and liver tissue samples. 
Compounds investigated Linear range of mixed 
standards (μg/mL)a 
n r2b Linear range of 
tissue samples 
(g/mL) 
n r2b Detection limit 
       pg on columnc S/N ratiod 
Amino acids 
Tyrosine 0.50–125.0 7 0.999 0.02–0.25 7 0.994 125.0 34.4 
Tryptophan 0.50–125.0 7 0.992 0.02–0.25 7 0.999 312.5 55.9 
Glycine 0.50–125.0 7 0.999 0.02–0.25 7 0.989 15.6 46.8 
Proline 0.50–125.0 7 0.996 0.02–0.25 7 0.996 15.6 56.9 
Aspartic acid 0.50–125.0 7 0.997 0.02–0.25 7 0.991 31.3 35.7 
Methionine 0.50–125.0 7 0.998 0.02–0.25 7 0.994 62.5 49.5 
Valine 0.50–125.0 7 0.998 0.02–0.25 7 0.997 15.6 47.2 
Alanine 0.50–125.0 7 0.997 0.02–0.25 7 0.987 15.6 80.9 
Serine 0.50–125.0 7 0.997 0.02–0.25 7 0.995 15.6 23.9 
Isoleucine 0.50–125.0 7 0.997 0.02–0.25 7 0.996 31.3 10.9 
Histidine 1.00–250.0 7 0.988 0.02–0.25 7 0.997 312.5 66.4 
Threonine 0.50–125.0 7 0.993 0.02–0.25 7 0.996 31.3 15.5 
Asparagine 0.50–125.0 7 0.999 0.02–0.25 7 0.996 31.3 4.8 
Ornithine 1.00–250.0 7 0.999 0.02–0.25 7 0.993 62.5 44.7 
Lysine 0.50–125.0 7 0.996 0.02–0.25 7 0.995 156.3 58.4 
4-Aminobutyric acid 0.50–125.0 7 0.995 0.02–0.25 7 0.983 31.3 46.9 
  
Organic acids 
Citric acid 0.50–125.0 7 0.992 0.02–0.25 7 0.985 312.5 56.7 
Succinic acid 0.50–125.0 7 0.996 0.02–0.25 7 0.993 15.6 49.1 
α-Ketoglutaric acid 1.00–250.0 7 0.997 0.02–0.25 7 0.989 625.0 20.5 
  
Carbohydrates 
Fructose 0.50–125.0 7 0.998 0.02–0.15 6 0.989 156.3 42.9 
Arabitol 1.00–250.0 7 0.999 0.02–0.25 7 0.985 125.0 65.2 
Gluconic acid 0.50–125.0 7 0.999 0.02–0.25 7 0.999 1562.5 99.9 
  
Fatty acids 
Tetradecanoic acid 1.00–250.0 7 0.996 0.05–0.25 6 0.999 31.3 35.2 
Hexadecanoic acid 1.00–250.0 7 0.999 0.02–0.25 7 0.986 15.6 109.8 
Oleic acid 1.00–250.0 7 0.997 0.02–0.25 7 0.983 125.0 32.4 
Octadecanoic acid 1.00–250.0 7 0.994 0.02–0.25 7 0.990 15.6 91.5 
  
Nucleotides 
Thymine 2.50–125.0 6 0.999 0.02–0.25 7 0.980 15.6 29.8 
Adenosine 2.50–125.0 6 0.997 0.05–0.25 6 0.977 625.0 14.8 
Uridine 1.00–250.0 7 0.998 0.02–0.15 6 0.990 1562.5 38.9 
aStandard compounds (stored at −4 °C before use) were diluted with water or methanol (for fatty acids). 
bCorrelation coefficients were calculated for the linear range listed in the table. 
cDetection limit (pg on column) is the lowest calibration standard injected with a S/N ratio ≥3. 
dS/N ratio was obtained using peak-to-peak values by ChromaTOF software. 
 
The linearity of liver tissue samples was also investigated. A series of 20, 50, 75, 100, 125, 150 
and 250 mg liver tissue samples were used in metabolite extraction by 500 μL solvent mixture of 
chloroform, methanol, and water (1:2:1, v/v/v) as the first step and another 500 μL methanol 
alone as the second step. Extracts were then dried and derivatized as described below. 
 
The correlation coefficients (r2) were calculated by the ratio of the peak area of each compound 
to the peak area of the corresponding internal standard in the analyzed concentration interval: l-
2-chlorophenylalanine was used when the retention time of the standard's peak was less than 
20 min and heptadecanoic acid used when the retention time was greater than 20 min. 
 
Limit of detection. To determine the limit of detection for each standard compound, a mixed 
standard solution was further diluted to concentrations of 0.0002, 0.0004, 0.0008 and 0.002 of 
their original concentrations, ranging from 25 to 250 pg/mL or 50 to 500 pg/mL. Each 100 μL 
mixture solution was added to the sampling vial with two internal standards and then dried in a 
vacuum centrifuge concentrator before subsequent derivatization. The signal-to-noise ratio was 
calculated in the data analysis interface of the Leco ChromaTOF software (v3.30). 
 
Precision, reproducibility, stability, and recovery. The instrument precision was obtained by 
continuously injecting the same sample vial of one mixed standard (12.5 or 25.0 μg/mL) six 
times and calculating the relative standard deviation (RSD) of the peak areas of standard 
compounds to the corresponding internal standard. The method reproducibility and stability were 
investigated using healthy rat liver tissue. Reproducibility was analyzed by repeating the whole 
method for the same liver tissue within a day (n = 6). Meanwhile, the stability test was 
performed by analyzing eight prepared samples from the same liver tissue on every other day 
within 1 week (ie, Days 1, 3, 5, 7; n = 2 for each day). The recovery of typical test metabolites 
was examined by adding mixed standards at three different concentrations (12.5, 25.0 and 
50.0 μg/mL, or 25.0, 50.0 and 100.0 μg/mL; n = 3 for each concentration) to 50 mg liver tissue 
samples. 
 
Derivatization procedure and GC/TOFMS analysis 
The derivatization procedure was conducted with minor modifications to the previous serum 
metabonomic study report [25]. Briefly, 80-μL methoxyamine (15 mg/mL in pyridine) was 
added to dry sample vials and vortexed for 30 s. Methoxymation was carried out at 30 °C for 
1.5 h. After adding another 80 μL BSTFA (containing 1% TMCS) and vortexing for 30 s, 
silylation was carried out at 70 °C for 1 h. Each 1-μL derivatized sample was injected into an 
Agilent 6890N gas chromatograph in splitless mode with time-of-flight mass spectrometry 
(Pegasus HT, Leco Co., CA, USA). Separation was achieved on a DB-5ms capillary column 
(30 m × 250 μm i.d., 0.25-μm film thickness; Agilent J&W Scientific, Folsom, CA, USA) using 
helium as the carrier gas, at a constant flow rate of 1.0 mL/min. The injector temperature was set 
at 270 °C. The GC oven temperature was set at 80 °C for the first 2 min, then programmed to 
ramp up 10 °C/min to 180 °C, 5 °C/min to 240 °C, 25 °C/min to 290 °C, and finally maintained 
at 290 °C for 9 min. Transfer line temperature and ion source temperature were set at 260 °C and 
200 °C, respectively. The mass spectra were obtained with electron impact ionization (70 eV) at 
full scan mode (m/z 30–600). 
 
Analysis of GC/TOFMS data 
All GC/TOFMS files were analyzed and converted to CDF format by ChromaTOF software 
(v3.30, Leco Co., CA, USA). CDF files were extracted using custom scripts (revised Matlab 
toolbox HDA, developed by Jonsson et al. [26,27]) in the MATLAB 7.0 (The MathWorks, Inc., 
USA) for data pretreatment procedures such as baseline correction, de-noising, smoothing and 
alignment, time-window splitting, and peak feature extraction (based on multivariate curve 
resolution algorithm) [27]. The resulting output data organized as arbitrary peak index (retention 
time-m/z pairs), sample names (observations), and peak intensity information (variables) were 
introduced into Simca-P 11.5 software (Umetrics, Umeå, Sweden) for principal components 
analysis (PCA), partial least squares (PLS) regression [28] and orthogonal partial least squares 
project to latent structures-discriminant analysis (OPLS-DA) [29]. Differential metabolites 
between model rat liver tissues and the controls generated from OPLS-DA model were identified 
by ChromaTOF software coupled with commercially available NIST library 2005 and some 
reference compounds. 
 
RESULTS AND DISCUSSION 
Extraction optimization 
The percentages of water and chloroform in the solvent mixture were both limited to 25% in our 
extraction procedure. This limitation was based on the results of our pre-experiments. When the 
percentage of water or chloroform increased, some compounds, especially carbohydrates such as 
glucose, lactose, and maltose, produced multiple peaks with high intensity and broadened peaks 
(data not shown). This would not only cause difficulty in quantifying these metabolites, but also 
mask adjacent peaks generated by other metabolites. In addition, excess amount of water in the 
extraction process would lead to precipitation in the samples after derivatization, putting gas 
chromatograph at risk of contamination; while too much of chloroform would cause the 
separation between organic and aqueous layers during extraction. 
 
A two-component PLS model [25,28] was generated to demonstrate the relationship between the 
X matrix (ie, the resolved peak areas of the metabolites of the 20 experimental samples in Table 
1; each peak area is one X-variable) and the design matrix Y (ie, the ratios of the solvent 
mixtures tested in Table 1; the amounts of the three solvent involved in the mixture are three Y 
variables). The two-component PLS scores plot (R2X = 0.602, R2Y = 0.943, Q2Y = 0.751) and the 
loading plots are shown in Fig. 1a and b. The first component explains 31.5% of the variance in 
the resolved peak areas, and the second component explains 28.7% of the variance. The PLS 
scores plot (t1–t2; Fig. 1a) shows how the areas of resolved peaks (X variables) correlate to the 
solvent compositions (shown as experiment number according to Table 1), and determine the 
distribution of experimental samples on the scores plot. For example, samples extracted with a 
mixture of chloroform, methanol, and water (Test Nos. 03, 07, 08, 09, 10; Table 1) are grouped 
together in the upper right quadrant of the plot; samples extracted with chloroform and methanol 
mixtures (Test Nos. 04 and 05) grouped in the upper left quadrant; samples with methanol alone 
(Test No. 01) located separately at the lower left quadrant. 
 
 
 
 
 
 
 
 
 
 
 
Figure 1: (a) The PLS scores t1 and t2 of the experimental samples. 
 
Each triangle stands for one designed experiment numbers in Table 1. (b) The PLS weights, w* (X-weights) and c (Y-weights), for X variables 
(the areas of the resolved GC/TOFMS peaks) and Y variables (designed proportion of the three solvent), respectively. 
 
The PLS loading plot (Fig. 1b, w*c-plot) summarizes the influence and correlation structure 
between variables in both the X matrix and the Y matrix. X variables with large w*'s (X-weights, 
positive or negative; situated far away from the origin in the w*c loading plot) are highly 
correlated with Y; while Y variables with large c's (Y-weights) are highly correlated with X. The 
w*c loading plot shows both the X-weights (w*) and the Y-weights (c), and thereby reveals how 
the X and Y variables combine in the projections, and how the X variables relate to the Y 
variables. From Fig. 1b, we can see that the first PLS component is mainly dominated by water 
(positively) and methanol (negatively), and the second component mainly by chloroform 
(positively) and methanol (negatively). Peak areas (X variables) near the center of the loading 
plot are less affected by the compositions of the solvent mixture, while peaks far from the center 
are greatly affected by solvents (Y variables), either positively or negatively. The wide 
distribution of peak areas in the loading plot implies the necessity of a two-step extraction with 
each step having a different ratio of solvent mixture for the extraction of these metabolites in 
liver tissue. Due to the opposing effect of methanol and water (chloroform) on most peak areas, 
experimental No. 01 (containing methanol alone) and experimental No. 03 
(chloroform:methanol:water = 1:2:1, v/v/v) were selected for each step of a two-step extraction, 
to maximize the number of metabolites effectively extracted for metabonomic analysis. 
 
Apart from PLS modeling analysis, we can observe the complementary extraction ability of 
solvent mixture 03 (chloroform:methanol:water = 1:2:1, v/v/v) and 01 (methanol alone) from 
Fig. 2a and b. By comparison, methanol alone (Fig. 2b) produced more intense peaks for 
lipophilic compounds (eg, hexadecanoic acid, oleic acid, octadecanoic acid, uridine, and 
cholesterol); while the peak intensities of hydrophilic compounds (eg, serine, threonine, proline, 
glutamine, and phosphoric acid) seem to abate gradually. 
 
 
Figure 2: Typical GC/TOFMS total ion current (TIC) chromatograms of liver tissue extracts 
using (a) one-step extraction (chloroform:methanol:water = 1:2:1, v/v/v), (b) one-step extraction 
(methanol alone), and (c) two-step extraction (first, chloroform:methanol:water = 1:2:1, v/v/v; 
second, methanol alone). 
 
 
 
 
 
The sequence of the two solvents chosen for the two-step procedure was also investigated to 
optimize the extraction procedure. The results suggest that the solvent mixture 
(chloroform:methanol:water = 1:2:1, v/v/v) should be used prior to methanol alone. This may be 
necessary because the solvent mixture removes water from the liver tissue, allowing methanol 
alone in the second step to extract more lipophilic metabolites. The two-step method (Fig. 2c) 
seems to be an acceptable compromise between the specialized extractions required by 
hydrophilic and lipophilic metabolites from liver tissue in one-step extractions, with more 
GC/TOFMS peaks resolved (Fig. 2). 
Method validation 
Linearity. The correlation coefficients (r2) for most of the 29 standards were higher than 0.99 (in 
the range of 0.5–125 or 1–250 μg/mL). Exceptions were thymine and adenosine which showed 
poor linear regression with lower concentration samples. The linearity was improved by 
excluding the low concentration data (Table 2). Similarly, the correlation coefficients (r2) for 
most of the corresponding metabolites in liver tissue were higher than 0.98 (in the range of 0.02–
0.25 g/mL); showing good linearity of the method (Table 2). 
 
Limit of detection. The threshold of signal-to-noise (S/N) ratio of 3.0 is generally used to 
determine the limit of detection of the compound of interest in mass spectral analysis. However, 
due to a large number of reference compounds, the limit of detection in our study was 
determined by the minimum concentration of these compounds detected, shown as pg on column 
(see Table 2), with an S/N value provided, usually greater than 3. 
 
Precision, reproducibility, stability, and recovery. The results demonstrate that the instrument 
has good precision. Approximately 40% of the compounds had RSD values below 5%, the rest 
were less than 8%. For most of the compounds investigated, the RSD values of reproducibility 
and stability were below 10% and 15%, respectively, demonstrating the reliability of the whole 
analytical method (see Table 3). The organic acids and fatty acids showed higher RSD values 
than other chemical classes investigated both for reproducibility and stability. As shown in Table 
4, mean recovery of typical metabolites ranged from 63.2% to 99.0% with almost all of the RSD 
of recovery lower than 10%, demonstrating the reliability of the extraction method. 
 
 
Table 3: Precision, reproducibility, and stability. 
Compounds Precision RSD (%): 
standards (n = 6) 
Reproducibility RSD (%): 
tissue samples (n = 6) 
Stability RSD (%): 
tissue samples (n = 8) 
Amino acids 
Tyrosine 3.4 4.8 8.1 
Tryptophan 6.0 6.7 9.0 
Glycine 6.5 9.7 11.2 
Proline 5.6 10.0 15.0 
Aspartic acid 6.2 8.3 8.5 
Methionine 5.0 9.3 9.2 
Valine 5.9 9.1 8.5 
Alanine 5.3 9.4 14.5 
Serine 6.5 8.0 8.6 
Isoleucine 4.9 9.4 11.0 
Histidine 2.8 12.3 14.0 
Threonine 6.1 8.4 9.6 
Asparagine 2.9 9.6 13.6 
Ornithine 2.9 6.0 6.9 
Lysine 3.3 9.9 5.9 
4-Aminobutyric acid 4.2 9.8 4.9 
  
Organic acids 
Citric acid 4.1 10.0 8.6 
Succinic acid 6.1 13.6 12.7 
α-Ketoglutaric acid 3.7 10.1 11.5 
  
Carbohydrates 
Fructose 7.3 8.1 8.9 
Arabitol 7.4 7.1 8.7 
Gluconic acid 3.6 7.5 7.7 
  
Fatty acids 
Tetradecanoic acid 3.6 10.1 14.7 
Hexadecanoic acid 3.8 15.9 15.2 
Oleic acid 3.5 12.0 18.2 
Octadecanoic acid 6.8 9.6 8.7 
  
Nucleotides 
Thymine 8.0 9.9 9.8 
Adenosine 6.7 9.5 13.5 
Uridine 7.9 5.0 9.1 
 
 
Table 4: Recovery of typical metabolites. 
Compounds Mean recovery (%)a RSD (%)a 
Tyrosine 92.9 4.7 
Tryptophan 80.5 6.6 
Proline 88.4 8.9 
Methionine 81.1 4.1 
Valine 87.4 7.2 
Serine 97.2 8.5 
Isoleucine 93.4 5.9 
Histidine 81.2 2.4 
Asparagine 85.0 7.7 
Ornithine 99.0 4.5 
Lysine 83.1 9.2 
Citric acid 66.0 6.0 
Arabitol 74.7 4.3 
Gluconic acid 92.4 1.7 
Adenosine 63.2 12.5 
aMean recovery and RSD were obtained by 9 determinations (3 parallel samples at 3 different concentrations) with the internal standard 
adjustment. 
 
 
Application 
Assays of serum and hepatic components and enzymes. Serum alanine aminotransferase 
(ALT), aspartate aminotransferase (AST), total bilirubin (TBIL), and cholesterol (CHOL) were 
measured with an auto-biochemistry detector in Shanghai Sixth Hospital (Shanghai, China). 
Hepatic malondialdehyde (MDA) and superoxide dismutase (SOD) were determined using 
commercial kits purchased from the Jiancheng Institute of Biotechnology (Nanjing, China). All 
values in Table 5 were presented as mean ± SD. For a single comparison between the two 
groups, t-test determined the significance of group differences. A level of P < 0.05 was taken as 
statistically significant and a level of P < 0.01 as most significant. As shown in Table 5, serum 
ALT and AST activities in rats intoxicated with CCl4 dramatically increased 24 h after the 
second injection. A significant increase in serum TBIL and hepatic MDA, and a significant 
decrease in serum CHOL and hepatic SOD in the model group were also observed. All the 
biochemical results indicated that CCl4 had already caused acute liver injury in the model rats. 
 
 
Table 5: Serum and hepatic biochemical analysis. 
Compounds Control (n = 10) Model (n = 10) 
ALT (U/L) 44 ± 8 901 ± 158a 
AST (U/L) 185 ± 35 1022 ± 173a 
TBIL (μmol/L) 2.3 ± 0.5 4.4 ± 1.4b 
CHOL (mmol/L) 1.3 ± 0.2 1.1 ± 0.3b 
MDA (nmol/mgprot) 5.8 ± 1.7 15.1 ± 6.9a 
SOD (U/mgprot) 182 ± 45 124 ± 55b 
aP < 0.01. 
bP < 0.05. 
 
Liver tissue metabonomic study. Liver tissues obtained from CCl4-induced liver injury model 
rats (n = 10) and control rats (n = 10) were treated with our established two-step extraction 
method and derivatization procedure. Fig. 3a shows obvious differences between the model and 
control groups in the typical GC/TOFMS total ion current (TIC) chromatograms. 
 
 
Figure 3: (a) Typical GC/TOFMS total ion current (TIC) chromatograms of liver tissue samples 
from a model rat (the upper) and a control rat (the bottom). The keys are provided in Table 6 and 
(b) OPLS-DA scores plot of GC/TOFMS data from liver tissue samples of models (triangle) and 
controls (square). 
 
 
 
 
To explore metabolic differences between the model rats and the control group, the obtained 
GC/TOFMS data were analyzed using multivariate statistics. The initial unsupervised PCA 
model illustrates the natural but clear separation between model and control samples (figure not 
shown). Additionally, an OPLS-DA model (R2Y = 0.976, Q2Y = 0.911; Fig. 3b) was constructed 
to identify the differential metabolites contributing to the separation of these two groups. The 
percentages of variance explained by the first and second components in the model are 23.6% 
and 16.0%, respectively. Variable importance in the projection (VIP) ranks the overall 
contribution of each variable (peak intensity) to the OPLS-DA model—variables with VIP > 1 
were selected as differential signals [9] and [12]. Accordingly, we identified a total of 18 
differential metabolites in our study using NIST library, and 11 of them were confirmed by 
standard compounds (Table 6). 
 
 
Table 6: A list of identified differential metabolites derived from multidimensional analysis. 
 Metabolites RT (min) VIPa Trendb 
1 Alaninec 6.14 1.38 ↓ 
2 beta-Hydroxybutyric acid 6.96 1.08 ↓ 
3 Phosphoric acid 7.19 1.24 ↑ 
4 Valinec 7.76 1.08 ↓ 
5 Urea 8.21 1.27 ↑ 
6 Glycerol 8.58 1.49 ↓ 
7 Isoleucinec 8.86 1.13 ↓ 
8 Succinic acidc 9.16 1.69 ↓ 
9 Uracil 9.47 1.81 ↑ 
10 Fumaric acidc 9.66 1.27 ↑ 
11 Malic acidc 11.42 1.27 ↑ 
12 Phenylalaninec 13.20 1.31 ↓ 
13 Arabitolc 13.80 1.73 ↓ 
14 Hypoxanthinec 15.70 1.19 ↓ 
15 Glucose 17.06 1.71 ↓ 
16 Gluconic acidc 18.07 1.25 ↓ 
17 Xanthinec 18.98 1.30 ↓ 
18 Maltose 27.41 1.71 ↓ 
aVariable importance in the projection (VIP) indicates the relative influence of each metabolite to the grouping; metabolites with higher VIP 
values are more influential. 
b↑ indicates that the metabolite is increased in the model compared to the control; ↓ indicates that the metabolite is decreased in the model 
compared to the control. 
cConfirmed by standard compounds in addition to NIST. 
 
 
CCl4 is widely used as a toxin to induce liver injury in rats. The toxicity induced by CCl4 is 
recognized by free radicals, mainly trichloromethyl radical ( CCl3) and its peroxyl radical (
OOCCl3), which initiate the chain reaction of lipid peroxidation and cause subsequent cell 
damage [30,31]. Recently, Huang et al. [32] performed GC/MS-based metabolic profiling of 
plasma in CCl4-induced mice and Lin et al. [33] introduced LC/MS for metabonomic analysis of 
urine from CCl4-induced rats. In the current study, we conducted metabonomic profiling of rat 
liver tissue, the precise location of CCl4-induced damage. Therefore, the differential metabolites 
derived from our liver-targeted metabonomic study may provide more direct biochemical 
information of the local acute phase response of hepatocytes after CCl4 intoxication. 
 
In our study, significant decreases in glucose, gluconic acid and maltose concentrations in the 
acute liver injury model group, as compared with control group, were observed. These may be 
the combined effects of both inhibited gluconeogenesis and glycolysis under oxidative stress 
caused by CCl4[34]. The decreased levels of the amino acids detected in the model group are 
consistent with the theory that CCl4 intoxication leads to the inhibition of amino acid uptake and 
protein synthesis [30,35]. TCA cycle is also found disturbed as important intermediates succinic 
acid declines; malic acid and fumaric acid augment in the model group. Meanwhile, the 
increased levels of malic acid, fumaric acid and urea observed in the model group may reflect the 
up-regulated urea cycle after CCl4 intoxication, which is also consistent with the decreases of 
many amino acids in the model. Moreover, significant increase in uracil and decreases in 
xanthine and hypoxanthine were also detected in the model group, which may indicate 
disturbances in nucleotide (pyrimidine and purine) metabolism in CCl4-induced acute liver 
injury rats. 
 
CONCLUSTION 
In this study, we developed and optimized a two-step extraction method for GC/TOFMS-based 
tissue metabonomic study, using a solvent mixture of chloroform, methanol, and water (1:2:1, 
v/v/v) for the first step, followed by a second extraction with methanol alone. This method has 
been extensively tested and validated using 29 standard compounds from different chemical 
classes and healthy rat liver tissues, and practically applied to metabonomic analysis of liver 
tissue samples from a rat model of CCl4-induced liver injury. Analytical variations due to the 
instrument and extraction method were insignificant compared to the biological variations 
associated with liver injury, proving the feasibility of this method in detecting perturbed 
metabolic networks in tissue metabonomic studies. 
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